Objective To investigate relationships between secondhand smoke exposure in young children and several preclinical markers of cardiovascular risk that have been established as relevant to adult populations.
T he latest report from the US Centers for Disease Control and Prevention (CDC) shows that, despite an overall reduction in secondhand smoke exposure from 1999 to 2015, 25% of the US population remains exposed. 1 Of special concern are children from low-income homes and African American children, because they have the highest rates of biologically measured secondhand smoke exposure. 1 More than 40% of US children aged 3-11 were exposed to tobacco smoke from 2011 to 2012, based on a biological marker of exposure, serum cotinine levels. 1 An inverse relationship between socioeconomic status and secondhand smoke exposure has been well-documented, 2, 3 and recent analyses have shown that for every decrease in family income ratio, serum cotinine levels increased by 1.18 ng/L among children. 2 This evidence, coupled with a burden of lifetime exposure, make young children of utmost concern. Better defining health risks of secondhand smoke in young children from low-income settings may help to underscore this health risk disparity and help pediatricians to enhance strategies to mitigate these risks.
Links between secondhand smoke and cardiovascular disease (CVD) and death in adults are very well established. [4] [5] [6] [7] Secondhand smoke is a known risk factor for the development of atherosclerotic heart disease and increases the risk of CVD by about 30% in nonsmoking adults. [5] [6] [7] In contrast with the compelling evidence in adults, studies demonstrating cardiovascular implications of secondhand smoke exposure during childhood are less defined. Young children are at particular risk for secondhand smoke exposure. 2, 8 More important, in our previous work, we demonstrated that toddlers had higher hair nicotine levels when compared with older children with equivalent survey measures of secondhand smoke exposure. 9 
BMI
Body mass index CDC US Centers for Disease Control and Prevention CRP C-reactive protein CVD Cardiovascular disease EPC Endothelial progenitor cell HDL High-density lipoprotein cholesterol MDA Malondialdehyde TAC Total antioxidant capacity TNF Tumor necrosis factor A challenge for studying cardiovascular risk in pre-adulthood is the fact that children and adolescents very rarely exhibit clinical manifestations of acquired (noncongenital) heart disease. Most adult forms of CVD are either related to or driven by inflammatory processes, 4 and such processes are apparently initiated in childhood. However, few studies have assessed the concurrent relationship between secondhand smoke exposure and cardiovascular risk markers in children <6 years of age. 10 Our goal was to better define the relationship between secondhand smoke exposure in toddlers age 2-5 years of age and preclinical CVD risk. We investigated several surrogate markers of CVD risks in relation to secondhand smoke exposure and included traditional clinical measures as well as research measures recognized as relevant and mechanistically involved in adult settings. Clinical measures were blood pressure, glucose metabolism, blood lipids, and markers of inflammation, and "research measures" were markers of oxidation, and vascular endothelial stress and endothelial repair. Each of these indicators has been linked to secondhand smoke exposure and CVD in adult or older pediatric populations, 7,11-14 but has not been investigated in very young children. Prior studies have not focused on this age group where the cardiovascular implications of secondhand smoke may be importantly under-recognized.
Methods
The Nationwide Children's Hospital Institutional Review Board approved the study. Participants were children aged 2-5 years, and parents provided informed consent. They were recruited via convenience sampling through recruiting in Nationwide Children's Hospital Primary Care Network (Columbus, Ohio), and advertising via an internal hospital e-mail system. The Primary Care Network primarily serves low-income, urban children in Columbus. Inclusion criteria were healthy children both exposed and unexposed to secondhand smoke by parental report. Exclusion criteria were the presence of ≥1 of the following: acute febrile illness or other active infections, congenital heart disease, diabetes (type 1 or 2), elevated fasting glucose (>100 mg/dL), family history of elevated cholesterol, use of oral or inhaled (anti-inflammatory) steroids within 11 month of testing, and/or not having enough hair for hair sampling of secondhand smoke exposure (hair nicotine level). This approach to enrollment thus avoided children with persistent asthma, because of the use of daily anti-inflammatories, which we considered confounding for this study.
The study was introduced to the mother or caregiver at a clinic visit. Subjects were subsequently scheduled for testing at a research site in the morning between 8 and 10 a.m., after overnight fasting. The protocol was carried out as follows: (1) Study procedures were described with parental informed consent and youth or teen assent and consent obtained, (2) anthropomorphic measurements obtained, (3) structured interview with subject and parent (demographics and secondhand smoke exposure history), (4) hair sample obtained, and (5) the blood sample of 7 mL was collected for biomarkers and covariates. After serum sample collection all assays were stored on ice and used within 12 hours of collection (24-hour for flow cytometry studies).
Trained research staff obtained height and weight from each subject using a Tanita BWB800 scale (Tanita Corporation of America, Inc, Arlington Heights, Illinois) and Seca stadiometer (Seca, Hamburg, Germany). Weights were recorded to the nearest 0.1 kilogram. Heights were measured to the nearest 0.5 cm. Body mass index (BMI) was determined according the CDC guidelines (BMI = weight [kg]/ height [m 2 ]), and percentile norms to define normal weight, overweight, and obese were from CDC guidelines (available at: http://www.cdc .gov/healthyweight/assessing/bmi/childrens_bmi/about _childrens_bmi.html).
Measured Variables
We assessed a comprehensive panel of clinically relevant and research-based outcome variables that have been used by others to reflect cardiovascular status and related disease risks. Brief descriptions of methods and rationale are provided.
Hair nicotine was used as a biological marker of secondhand smoke exposure to assess long-term evaluation of smoke exposure because the nicotine is incorporated into the growing hair shaft over several months. Samples are easy to obtain, handle, and store. Approximately 20-40 hair shafts from the occipital area were cut at the root and 2-3 cm in length. Hairs were stored and later sent for assay at an established contract research facility (Johns Hopkins School of Public Health). Between 10 and 30 mg of each hair sample were washed using 3 mL of dichloromethane and sonicated (Model 250HT, Aquasonic, Hayward, California) for 30 minutes before nicotine extraction and analysis. This process removed any nicotine adherent to the surface of the hair, limiting measurement of nicotine to that accumulated by inhalation, ingestion, and dermal absorption, and subsequent incorporation into the growing hair. Hair nicotine analysis was performed using gas chromatography/mass spectrometry (GC-17/MS-QP5000, Shimadzu, Canby, Oregon) in selected ion monitoring and splitless modes. For quality control, approximately 10% of the hair samples were subjected to duplicate analyses. Content is expressed as ng/mg of hair.
Blood pressure was measured via a Critikon-Dinamap Compact T monitor (Critikon Inc, Tampa, Florida). The subject was fasting and allowed upright (typically in a parent's lap) for ≥5 minutes; the measurement is taken on the subject's left arm. Normalized blood pressure (percentile of normative values) was derived from National Heart, Lung, and Blood Institute tables, accounting for height, age, and sex (http://www .nhlbi.nih.gov/guidelines/hypertension/child_tbl.htm).
Fasting lipid profiles and glucose were measured via our hospital core laboratory facility. Insulin was determined by enzyme immunoassay (GenWay Biotech Inc, San Diego, California, Cat# 40-056-205011).
Biomarkers of Inflammation C-Reactive Protein. C-reactive protein (CRP) was measured as a classical and clinically relevant measure of systemic inflammation that has been linked to secondhand smoke THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 189 • October 2017 exposure in both adults and children. 11, 15 Elevation in serum CRP levels has been demonstrated in many forms of adult heart disease and is a strong independent predictor of CVD risk in adults. 16 This was measured using a commercially available enzyme immunoassay test kit (BioCheck, Inc, Foster City, California; Cat # BC-1119). Intra-assay and interassay variations are <5% and 11%, respectively. Serum IL-6 and Tumor Necrosis Factor. These cytokines were measured as research-based markers of systemic inflammation. Both IL-6 and tumor necrosis factor (TNF)-a have been correlated with adiposity in children 6-19 years of age. Association of these markers with secondhand smoke is less known, especially in young children. Plasma IL-6 levels were determined using a highly sensitive ELISA kit (R&D systems, Minneapolis, Minnesota; Cat # DY206). Intra-assay and interassay variations are <8% and 10%, respectively.
Biomarkers of Oxidation
Protein Malondialdehyde Adducts. This is a measure of lipid peroxidation in serum. 17 Malondialdehyde (MDA) is a highly reactive 3-carbon dialdehyde byproduct of fatty acid peroxidation. We have found significant relationships between protein MDA and hair nicotine level in obese teenagers. 18 These were measured by OxiSelect MDA Adduct competitive ELISA kits (Cell Biolabs, Inc, San Diego, California, Cat#STA-832-5). The quantity of MDA adduct in samples was determined by comparing its absorbance with that of a predetermined MDA-bovine serum albumin standard curve, and reported as pmol MDA/mL.
Total Plasma Antioxidant Capacity. This measurement provides a nonspecific measure of "antioxidant reserve" in plasma and is thus an indication of the overall capability to counteract reactive oxidizing species and combat oxidative stressrelated diseases. It has been shown to be reduced in many settings of chronic inflammation and oxidation. 19 Both small molecule and protein antioxidants are measured in aggregate, and results are presented as mmol/L Trolox equivalents (a reference reagent with quantitative antioxidant capacity). Commercial assay kits were from Biovision Research Products (Cat#K274-100, Mountain View, California). Trolox was used as a standard antioxidant and total plasma antioxidant capacity was expressed as mmol/L Trolox equivalents.
Biomarkers of Vascular Endothelial Stress
Soluble Intercellular Adhesion Molecule-1. Soluble intercellular adhesion molecule-1 was measured as a biomarker of endothelial stress and activation. Elevations in this marker have been documented in several settings of vascular injury (including coronary heart disease), and in relation to secondhand smoke exposure. 13 Levels of soluble intercellular adhesion molecule-1 were determined using a sensitive commercially available ELISA kit (R&D Systems; Cat # DY720). Intra-assay and interassay variations are <5% and 10%, respectively.
Circulating Endothelial Progenitor Cells. Endothelial progenitor cells (EPCs) are bone marrow-derived stem cells that have the ability to differentiate into functional endothelial cells, circulate in the blood, and home preferentially to sites of vascular or tissue injury, contributing significantly to both endothelial repopulation and neovascularization. 20 These cells have been recognized as a potential surrogate biological marker for vascular function and cumulative cardiovascular risk in adults. 21, 22 Decreased EPC number and function have been shown in adult nonsmokers exposed to secondhand smoke, 23 but have not been studied in relationship to secondhand smoke exposure in young children.
A volume of 50 µL anticoagulated peripheral blood was incubated with 50 µL 3% bovine serum albumin in phosphatebuffered (without Ca ++ and Mg ++ ) at room temperature for 30 minutes. In dark, fluorescence labeled antibodies (2.5 µL of each), PE-CD133, FITC-CD34, and PECy5-CD45, were added and incubated for 30 minutes at room temperature. FACS lysis buffer (450 µL) was then added, and incubated for 30 minutes at room temperature in dark. Samples were then analyzed on FACS caliber flow cytometer, where total counts were >400 000 cells. Prevalence of CD34
+ /CD45 -, CD133
-cells was expressed as the percentage of total events.
Statistical Analyses
Statistical analyses were performed with Stata 13.1 (StataCorp 2013 Stata Statistical Software: Release 13.0; Stata Corporation, College Station, Texas). P ≤ .05 was considered statistically significant. Categorical variables were used to indicate sex (female = 1, male = 0), race (African American, White, Biracial, and other race), ethnicity (Hispanic or Latino = 1, NonHispanic = 0), insurance status (Medicaid benefits = 1, all other insurance = 0), and maternal education (less than high school, high school graduate or General Education Development, some college, or college graduate or higher).
Continuous outcome variables were used for child's systolic blood pressure, diastolic blood pressure, systolic blood pressure percent, diastolic blood pressure percent, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol (HDL), fasting glucose, fasting insulin, CRP, IL-6, TNF-a, plasma protein MDA, total antioxidant capacity, soluble intercellular adhesion molecule-1, and EPC prevalence. In multivariate regression analysis, fasting insulin, CRP levels, IL-6, TNF-a, plasma protein MDA, and EPC prevalence were transformed logarithmically to improve the distribution of these variables. Age and BMI were also modeled as continuous measures. BMI was converted to a BMI z-score. A program available in Stata, zscore06, was used to calculate anthropometric z-scores. Length-for-age, height-for-age, weightfor-height, BMI-for-age, and weight-for-age z-scores were calculated.
All variables found to be non-normally distributed were log transformed for any subsequent analyses. Bivariate associations between baseline demographic characteristics, secondhand smoke, and all cardiovascular outcomes were examined first using Pearson correlations. Multivariate linear regression with robust standard errors, clustered on family identification to account for the clustering of children within the same October 2017 ORIGINAL ARTICLES family, was used to model each of the cardiovascular outcomes separately. All models included covariates for sex, race, ethnicity, insurance status, maternal education, age, and BMI z-score. Descriptive statistics are presented for all variables (means and SD for normally distributed and medians and IQRs for skewed variables). Only significant models are presented for the multivariate models. Among the 149 children 2-5 years of age included in the study, 10 had missing information on maternal education, for a final sample size of 139. Additionally, 8 children had missing information on systolic blood pressure, and systolic blood pressure percent and 9 had missing values for EPC prevalence. The models for CRP and total antioxidant capacity (TAC) each had 1 additional missing case. Because models were run separately by outcome, the final sample size for blood pressure was n = 131, TAC n = 138, CRP n = 138, and for EPC n = 122. All other models presented had the full sample, minus those missing maternal education, n = 139. Sensitivity analysis has confirmed that there are no differences with or without missing cases.
Results
Characteristics of the study subjects are shown in Table I . The average age was 3.2 years, and the majority (82%) was of lower socioeconomic status (insured through Medicaid), with a minority of mothers having a college degree or higher (14%). Onethird of the group was either overweight (10.7%) or obese (22.8%).
The enrolled participants had a wide range in smoke exposures and a significant proportion were exposed substantially (Table I) ; 66.4% of subjects lived with a smoker, and 40 (26.8%) lived with ≥2 smokers. Maternal smoking was present in 62 of the enrolled subjects (42.3%). As expected from other studies, hair nicotine levels were detectable in all subjects (even those with no reported exposures), were not normally distributed, and encompassed a thousand-fold range in values. The median was 1.86 ng/mg, with an average hair nicotine of 5.51 ng/mg (SD 8.43), and a wide range of exposure levels from 0.03 ng/mg (virtually no exposure) to 39.45 ng/mg. Table II presents the results of all outcome variables analyzed. Means and SDs are presented for the normally distributed variables, medians and IQRs are presented for the variables with skewed distributions. All variables that were found to have non-normal distribution were log-transformed for any subsequent data analyses.
Preliminary bivariate analyses were performed using Pearson correlations, examining the associations between logtransformed hair nicotine vs each other demographic and other measured variables (n = 131-139 for each pairwise analysis). Shown in the Figure is a multipanel presentation of the 8 variables that were found to be significantly correlated with logtransformed hair nicotine levels. After Bonferroni adjustments per family of variables (blood pressure, inflammation, lipids, glucose, endothelial stress, and EPCs), log hair nicotine remained significantly related to most of the variables before the Bonferroni adjustment. Log hair nicotine was positively related to systolic blood pressure percent (Pearson r = 0.30; P = .003), and inversely related to total cholesterol (Pearson r = −0.23; P = .03) and HDL (Pearson r = −0.23; P = .02). Log hair nicotine was significantly positively related to log CRP (Pearson r = 0.21; P = .04), and negatively related to EPC prevalence (Pearson r = −0.28; P = .01). There was no relationship between log hair nicotine and diastolic blood pressure percent, triglycerides, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, fasting glucose levels, insulin levels, IL-6, TNF-a, MDA, TAC, and soluble intercellular adhesion molecule-1. Separate multivariate linear regression analysis (clustered on family identification with robust standard errors) examined the relationship between log-transformed hair nicotine and all cardiovascular outcomes above. Each row represents a separate regression model with the outcome measures listed in the first column; unstandardized coefficients and standard errors are presented. All models included controls for sex, age, race, ethnicity, method of payment, maternal education, and BMI z-score (Table III) . Log hair nicotine was related independently and significantly to systolic blood pressure, systolic blood pressure percentile, HDL, CRP, TAC, and EPC prevalence. BMI z-score was also independently related to systolic blood pressure, systolic blood pressure percent, and HDL; however, no interaction effect was found between BMI and hair nicotine for any of the cardiovascular risk measures. Examining the clinical variables, each single log increase in hair nicotine (corresponding to 2.72 ng/mg hair) was associated with an increase of 4.68 mm Hg for systolic blood pressure, a 0.92 mg/L increase in CRP, and a 4.42 mg/dL decrease in HDL. Regarding the research variables, each log increase of hair nicotine was associated with a decrease of 0.68 units for EPC prevalence and 6.872 units (mmol/LTrolox equivalents) in total antioxidant capacity.
Discussion
Although secondhand smoke is now recognized as a significant contributor to cardiovascular risks in older age groups, the toddler population has not been studied. The characteristics of the children we enrolled match a population of very high concern for secondhand smoke exposure (urban, African American, low income). 24 More than one-half of the study participants lived with ≥1 smokers, and many of the participants had hair nicotine levels equivalent to published values associated with adult active smokers. This subgroup of US children is of very high concern regarding secondhand smoke exposure and later tobacco consumption and related disease risks.
In the present study, we evaluated an array of cardiovascular risk markers that encompassed clinical measures (blood pressure, lipids, glucose metabolism, inflammation) as well as 3 recognized aspects of tobacco-related mechanisms of injury in adults, so-called research measures (oxidation, vascular endothelial injury, and vascular repair). The apparently healthy toddler cohort had a wide range of values in these biomarkers. Secondhand smoke exposure was independently linked to higher systolic blood pressure, HDL reduction, CRP elevation (a marker of inflammation), TAC reduction (a marker of oxidation), and EPC reduction (a marker of vascular repair). These relationships are all mechanistically relevant and apparently occurring simultaneously at a very young age. These data extend prior work on the cardiovascular effects of tobacco exposure to a younger age group than previously studied.
Similar to our previous observations, 9, 13 in this study we found that nearly all children had measurable hair nicotine levels via the highly sensitive mass spectrometry analytical assay used. This is routinely described in the literature in children and other age groups, and is likely related to the widespread exposures that humans have with respect to tobacco products. Aside from our own work, a recent study done by Kim et al 25 showed that "no secondhand smoke exposure" in adults provided a median hair nicotine level of 0.23 ng/mg using identical collection and analysis procedures. For these reasons, there is no clear precedent in the child secondhand smoke literature regarding a cutpoint for true zero exposure. In preliminary analyses, we did conduct a receiving operating characteristic analysis with our sample to see what cut points could be used examining children who lived with a smoker vs those who did not and children whose mothers smoke vs those who did not. At 80% sensitivity, for both living with a smoker and having a mother who smokes, our results suggested a cut point of 0.32 ng/mg; this is a similar value to studies in adults showing that nonsmokers (eg, controls) have levels of 0.2-0.3 ng/mg. Using such a cutpoint would have limited any subanalysis to only 5 children; we therefore used correlation analyses to take advantage of our entire dataset.
Our findings demonstrate that health disparities noted during adulthood may at least be partially accounted for by early life secondhand smoke exposure. Epidemiologic studies have shown the association between low socioeconomic status during childhood and increased cardiovascular morbidity and mortality during adult life. 26 The lifetime health burden of youth who are exposed to secondhand smoke is bound to be significant. For example, a recent analysis of the Bogalusa Heart Study has shown that secondhand smoke exposure during childhood only showed a stronger association with cardiovascular risk than exposure in adulthood only, 27 suggesting an "imprinting effect" of secondhand smoke-related disease risks. In addition to cumulative effects of years of exposure, children who grow up with smokers also are at greater risk of becoming active smokers owing to the parental modeling of smoking behavior. 28 Obesity prevalence also varies inversely with socioeconomic status, 29 and we noted an independent relationship between BMI z-score and systolic blood pressure and lower HDL among this group. Our goal should be to enhance our identification of the children at greatest risk and develop effective strategies to intervene and prevent adult CVD.
One strength of this study is the focus on highly exposed, low-income, city-dwelling children who may be the most vulnerable to physiological perturbations of secondhand smoke exposure. A convenience sample rather than a random or epidemiologically based sample is a potential limitation of this study, but we have no reason to believe that the relationships between secondhand smoke and outcomes investigated would be different owing to sampling technique. We controlled for potential confounders including age, race, maternal education, method of payment, and BMI z-score, and acknowledge that this was a cross-sectional study, from which we can infer correlation but not causation. However, our findings are biologically plausible and align with previous data from older children, teens, and adults.
Another potential limitation is that we excluded children with persistent asthma. This exclusion would have biased our findings toward the null by excluding children with the most inflammation, so that we may have underestimated the relationships between secondhand smoke and inflammation. Studies to understand the complete picture of cardiovascular and pulmonary risks and disease course patterns are needed, especially in young children.
It is clear that, in the US, secondhand smoke exposure is a health-risks disparity, and this study illustrates that these risks are apparent even in the very young. The American Heart Association has concluded that secondhand smoke is a compelling threat to cardiovascular health in children and that current evidence warrants "a robust public health policy that embraces zero tolerance of childhood secondhand smoke exposure." 30 Our study supports these views, because we found an objectively measured marker of secondhand smoke (hair nicotine) was strongly correlated to several variables already well-established as cardiovascular risk markers in adults. The pervasive exposure of secondhand smoke in children could, therefore, be an important contributor to CVD risks that are established in very early life but clinically manifested later and our observations may help to catalyze actions for protection of young children from tobacco-related disease risks.
The prevalence and magnitude of traditional CVD markers in 2-to 5-year-old children in this study of apparently healthy normal children could perhaps serve as an alarm to pediatricians and others concerned with public health and CVD trends, but more insight is clearly needed. Longitudinal studies to better define the sequencing of pathophysiological mechanisms and actual disease consequences are needed (albeit difficult to conduct). Additional efforts to develop risk stratification strategies in subgroups of young children could also create opportunities for selective early interventions and treatments. Other studies to define interactions of secondhand smoke and other coincidental disease risks in early life, and to ultimately reduce or prevent secondhand smoke exposure in the homes of young children and elsewhere are important goals. Given the substantial evidence that adult heart disease is a pediatric concern, such studies in children are clearly warranted. 
